Aug 15, 2023 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited second-quarter 2023 earnings conference call. (Operator Instructions) This conference is being recorded today, August 15, 2023. I'd now like to turn the call over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.
Scott Powell - VolitionRx Limited - EVP, IR & CFO of Volition America, Inc.
Thank you, and welcome, everyone, to today's earnings conference call for VolitionRx Limited. This call will cover Volition's financial and operating results for the second quarter of 2023, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session. Also, on our call today, Mr. Cameron Reynolds, President and Group Chief Executive Officer; Mr. Terig Hughes, Group Chief Financial Officer; and Dr. Tom Butera, Chief Executive Officer of the Volition Veterinary subsidiary.
Before we begin, I'd like to remind everyone that some of
Q2 2023 VolitionRX Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
